{"transactions":[{"id":1800360,"issuer":{"id":7362,"kind":"organization","name":"MIRA PHARMACEUTICALS, INC."},"owners":[{"id":94481,"kind":"person","name":"Nicholoudis Christos","position":1,"cik":"0001984816","reported_name":"Nicholoudis Christos","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options","published_at":"2023-08-21T22:00:18.000Z","date":"2023-08-17","kind":"grant","planned":false,"acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The exercise price of the stock options issued to the Reporting Person is equal to the closing price of the Issuer's common stock on August 17, 2023."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock options were issued to the Reporting Person on August 17,2023, pursuant to a grant under the Issuer's 2022 Omnibus Incentive Plan, as amended and restated. The award vested in full on August 17,2023."}],"balance_after":10000,"derivative":{"exercise_price":6.5,"expiration_date":"2033-08-17","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001493152-23-029734","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1904286/000149315223029734/ownership.xml","form_type":"4"}}]}